Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07341334 · ClinicalTrials.gov registry record

Digital Speech Markers for Monitoring ALS in Spanish Speakers

A clinical trial, sponsored by Nova Southeastern University.

Not yet
Registry status
35
Enrollment target

NCT07341334 is a clinical trial that has not yet begun recruiting, run by Nova Southeastern University. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07341334 has not yet begun recruiting, sponsored by Nova Southeastern University.

NOT YET RECRUITING
Registry status
35 participants
Enrollment target

Study Summary

The goal of this observational study is to learn how speech and breathing change over time in Spanish-speaking individuals with amyotrophic lateral sclerosis (ALS) compared to age- and gender-matched individuals without ALS. The main questions it aims to answer are: Can speech and breathing measures collected through a smartphone application serve as reliable digital biomarkers to track bulbar disease decline in Spanish-speaking people with ALS? How do these measures differ between individuals with ALS and those without ALS? Researchers will compare Spanish-speaking participants with ALS to age- and gender-matched healthy controls to see if specific speech and breathing features can identify or predict bulbar decline. Participants will: Use a Spanish-language smartphone application to record speech and breathing tasks over time. Complete assessments of speech, breathing, and functional abilities (e.g., ALS Functional Rating Scale). Provide data that will be compared to caregiver reports and clinical outcomes to validate new digital biomarkers.

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2026-04
Est. Completion 2029-12

Sponsor

Nova Southeastern University

71 total trials

What the Registry Record Tells You About NCT07341334

The ClinicalTrials.gov registry entry for NCT07341334 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT07341334 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07341334 about?

NCT07341334 is a clinical study titled "Digital Speech Markers for Monitoring ALS in Spanish Speakers". The goal of this observational study is to learn how speech and breathing change over time in Spanish-speaking individuals with amyotrophic lateral sclerosis (ALS) compared to age- and gender-matched individuals without ALS. The main questions it aims to answer are: Can speech and breathing measur...

What is the current status of trial NCT07341334?

This trial is currently not yet recruiting. The enrollment target is 35 participants. The study started on 2026-04. Estimated completion is 2029-12.

Who is sponsoring clinical trial NCT07341334?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.